Newsletter | December 2024

Curious about what matters most when exploring CMO partnerships? We'd like to share insights to best serve clients' diversifying and most current needs through an overview of Samsung Biologics’ manufacturing capabilities. Learn about how our experience and services can help streamline processes and meet quality standards.

COMPANY NEWS

Samsung Biologics listed in Dow Jones Sustainability World Index

Samsung Biologics has been listed among the most sustainable companies in the Dow Jones Sustainability World Index (DJSI), a globally recognized benchmark for evaluating the sustainability performance of over 2,500 publicly traded companies. As a trusted CDMO partner, the company will continue advancing its ESG objectives through decarbonization efforts and effective supply chain management to help create a healthier future. Read more

Supplier ESG day

Samsung Biologics hosted its second Supplier ESG Day to share insights on sustainable management and encourage ESG actions among suppliers. Held virtually to reach more domestic and global suppliers, the event welcomed participation from over 82 companies, including Merck, Cytiva, Thermo Fisher, and Sartorius. Read more

What defines a quality culture at Samsung Biologics?

What defines a culture that revolves around quality of biologics, ones that serve the basis for medicines reaching patients? Learn more through our latest Newsroom article, where our experts share what drives them to maintain a quality culture that permeates processes and teams.

BIO INSIGHTS

Overcoming viral clearance challenges

For successful viral clearance, complex challenges including virus carryover must be resolved early on to develop safe, high quality drugs. This article explains how working with an experienced CDMO partner can help clients overcome obstacles, avoid production delays, and ensure on-time delivery. Read more

A strategic roadmap for your biologics manufacturing

Streamline your biologics manufacturing journey with integrated end-to-end services that ensure quality at every stage. Learn how Samsung Biologics’ approach accelerates time to market and help you deliver the highest-quality products.

This year, Samsung Biologics continued to work side-by-side with clients, supporting the delivery of high-quality biopharmaceuticals to patients with unmet needs and contributing to a healthier tomorrow. As we bid 2024 farewell, here's a look back at the key highlights that defined Samsung Biologics during the past 12 months and laid the foundation for another successful year to come.

UPCOMING EVENT